UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 164

Sortiert nach

Update in Lung Cancer Molecular Pathology: Technological Advances and Clinical Practice

Cancers, 2023-07, Vol.15 (15), p.3812

2023

Volltextzugriff (PDF)

A Brief Report of Transformation From NSCLC to SCLC: Molecular and Therapeutic Characteristics

Journal of thoracic oncology, 2019-01, Vol.14 (1), p.130-134

2019

Volltextzugriff (PDF)

K-RAS mutations indicating primary resistance to crizotinib in ALK -rearranged adenocarcinomas of the lung: Report of two cases and review of the literature

Lung cancer (Amsterdam, Netherlands), 2016-03, Vol.93, p.55-58

2016

Volltextzugriff (PDF)

Incidence and clinicopathologic features of gastrointestinal stromal tumors. A population-based study

BMC cancer, 2007-12, Vol.7 (1), p.230-230, Article 230

2007

Volltextzugriff (PDF)

Synchronous occurrence of squamous-cell carcinoma “transformation” and EGFR exon 20 S768I mutation as a novel mechanism of resistance in EGFR -mutated lung adenocarcinoma

Lung cancer (Amsterdam, Netherlands), 2017-01, Vol.103, p.24-26

2017

Volltextzugriff (PDF)

The challenge of NSCLC diagnosis and predictive analysis on small samples. Practical approach of a working group

Lung cancer (Amsterdam, Netherlands), 2012-04, Vol.76 (1), p.1-18

2012

Volltextzugriff (PDF)

Adipose-Derived Mesenchymal Stem Cells as Stable Source of Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand Delivery for Cancer Therapy

Cancer research (Chicago, Ill.), 2010-05, Vol.70 (9), p.3718-3729

2010

Volltextzugriff (PDF)

Inter-relationship between PD-L1 expression and clinic-pathological features and driver gene mutations in pulmonary sarcomatoid carcinomas

Lung cancer (Amsterdam, Netherlands), 2017-11, Vol.113, p.93-101

2017

Volltextzugriff (PDF)

BRAF as a positive predictive biomarker: Focus on lung cancer and melanoma patients

Critical reviews in oncology/hematology, 2020-12, Vol.156, p.103118-103118, Article 103118

2020

Volltextzugriff (PDF)

MET and Small-Cell Lung Cancer

Cancers, 2014-10, Vol.6 (4), p.2100-2115

2014

Volltextzugriff (PDF)

Robust Performance of the Novel Research-Use-Only Idylla GeneFusion Assay Using a Diverse Set of Pathological Samples with a Proposed 1-Day Workflow for Advanced NSCLC Evaluation

Cancers, 2022-12, Vol.15 (1), p.292

2022

Volltextzugriff (PDF)

Clinicopathological Features of Non-Small Cell Lung Carcinoma with BRAF Mutation

Current oncology (Toronto), 2023-11, Vol.30 (11), p.10019-10032

2023

Volltextzugriff (PDF)

Expression of programmed cell death ligand 1 in non–small cell lung cancer: Comparison between cytologic smears, core biopsies, and whole sections using the SP263 assay

Cancer cytopathology, 2019-02, Vol.127 (1), p.52-61

2019

Volltextzugriff (PDF)

Dissecting Pulmonary Large-Cell Carcinoma by Targeted Next Generation Sequencing of Several Cancer Genes Pushes Genotypic-Phenotypic Correlations to Emerge

Journal of thoracic oncology, 2015-11, Vol.10 (11), p.1560-1569

2015

Volltextzugriff (PDF)

Morphology and a limited number of immunohistochemical markers may efficiently subtype non-small-cell lung cancer

Journal of clinical oncology, 2009-10, Vol.27 (28), p.e141-e142

2009

Volltextzugriff (PDF)

Tackling ALK in non-small cell lung cancer: the role of novel inhibitors

Translational lung cancer research, 2016-06, Vol.5 (3), p.301-321

2016

Volltextzugriff (PDF)

Role of Chemotherapy and the Receptor Tyrosine Kinases KIT, PDGFRα, PDGFRβ, and Met in Large-Cell Neuroendocrine Carcinoma of the Lung

Journal of clinical oncology, 2005-12, Vol.23 (34), p.8774-8785

2005

Volltextzugriff (PDF)

Clofarabine, cyclophosphamide and etoposide for the treatment of relapsed or resistant acute leukemia in pediatric patients

Leukemia & lymphoma, 2012-09, Vol.53 (9), p.1693-1698

2012

Volltextzugriff (PDF)

Multiparametric molecular characterization of pulmonary sarcomatoid carcinoma reveals a nonrandom amplification of anaplastic lymphoma kinase (ALK) gene

Lung cancer (Amsterdam, Netherlands), 2012-09, Vol.77 (3), p.507-514

2012

Volltextzugriff (PDF)

Nivolumab-Induced Impressive Response of Refractory Pulmonary Sarcomatoid Carcinoma with Brain Metastasis

Case reports in oncology, 2018-09, Vol.11 (3), p.615-621

2018

Volltextzugriff (PDF)

Gene mutations in small-cell lung cancer (SCLC): Results of a panel of 6 genes in a cohort of Italian patients

Lung cancer (Amsterdam, Netherlands), 2014-12, Vol.86 (3), p.324-328

2014

Volltextzugriff (PDF)

Immunhistochemistry by Means of Widely Agreed-Upon Markers (Cytokeratins 5/6 and 7, p63, Thyroid Transcription Factor-1, and Vimentin) on Small Biopsies of Non-small Cell Lung Cancer Effectively Parallels the Corresponding Profiling and Eventual Diagnoses on Surgical Specimens

Journal of thoracic oncology, 2011-06, Vol.6 (6), p.1039-1049

2011

Volltextzugriff (PDF)

mTOR Pathway Expression as Potential Predictive Biomarker in Patients with Advanced Neuroendocrine Tumors Treated with Everolimus

Cancers, 2020-05, Vol.12 (5), p.1201

2020

Volltextzugriff (PDF)

Diagnosis of anaplastic lymphoma kinase rearrangement in cytological samples through a fluorescence in situ hybridization–based assay: Cytological smears versus cell blocks

Cancer cytopathology, 2017-05, Vol.125 (5), p.303-312

2017

Volltextzugriff (PDF)

ALK Rearrangement Testing by FISH Analysis in Non–Small-Cell Lung Cancer Patients: Results of the First Italian External Quality Assurance Scheme

Journal of thoracic oncology, 2014-10, Vol.9 (10), p.1470-1476

2014

Volltextzugriff (PDF)

1 – 25 von 164

Suche als RSS-Feed

Aktive Filter

ThemaOncology

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(150)
Mit Volltextzugriff
(154)

Publikationsform

Artikel
(163)
Buchkapitel
(1)

Sprache

Englisch
(164)
Japanisch
(28)

Erscheinungsjahr

n.n

Thema

14 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

Lung Cancer
(27)
Journal Of Thoracic Oncology
(23)
Cancers
(7)
Journal Of Clinical Oncology
(6)
Endocrine Pathology
(5)
Tumori
(5)
Leukemia & Lymphoma
(4)
Anticancer Research
(3)
Breast Cancer Research And Treatment
(3)
Cancer Cytopathology
(3)

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Update in Lung Cancer Molecular Pathology: Technological Advances and Clinical Practice

A Brief Report of Transformation From NSCLC to SCLC: Molecular and Therapeutic Characteristics

K-RAS mutations indicating primary resistance to crizotinib in ALK -rearranged adenocarcinomas of the lung: Report of two cases and review of the literature

Incidence and clinicopathologic features of gastrointestinal stromal tumors. A population-based study

Synchronous occurrence of squamous-cell carcinoma “transformation” and EGFR exon 20 S768I mutation as a novel mechanism of resistance in EGFR -mutated lung adenocarcinoma

The challenge of NSCLC diagnosis and predictive analysis on small samples. Practical approach of a working group

Adipose-Derived Mesenchymal Stem Cells as Stable Source of Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand Delivery for Cancer Therapy

Inter-relationship between PD-L1 expression and clinic-pathological features and driver gene mutations in pulmonary sarcomatoid carcinomas

BRAF as a positive predictive biomarker: Focus on lung cancer and melanoma patients

MET and Small-Cell Lung Cancer

Robust Performance of the Novel Research-Use-Only Idylla GeneFusion Assay Using a Diverse Set of Pathological Samples with a Proposed 1-Day Workflow for Advanced NSCLC Evaluation

Clinicopathological Features of Non-Small Cell Lung Carcinoma with BRAF Mutation

Expression of programmed cell death ligand 1 in non–small cell lung cancer: Comparison between cytologic smears, core biopsies, and whole sections using the SP263 assay

Dissecting Pulmonary Large-Cell Carcinoma by Targeted Next Generation Sequencing of Several Cancer Genes Pushes Genotypic-Phenotypic Correlations to Emerge

Morphology and a limited number of immunohistochemical markers may efficiently subtype non-small-cell lung cancer

Tackling ALK in non-small cell lung cancer: the role of novel inhibitors

Role of Chemotherapy and the Receptor Tyrosine Kinases KIT, PDGFRα, PDGFRβ, and Met in Large-Cell Neuroendocrine Carcinoma of the Lung

Clofarabine, cyclophosphamide and etoposide for the treatment of relapsed or resistant acute leukemia in pediatric patients

Multiparametric molecular characterization of pulmonary sarcomatoid carcinoma reveals a nonrandom amplification of anaplastic lymphoma kinase (ALK) gene

Nivolumab-Induced Impressive Response of Refractory Pulmonary Sarcomatoid Carcinoma with Brain Metastasis

Gene mutations in small-cell lung cancer (SCLC): Results of a panel of 6 genes in a cohort of Italian patients

Immunhistochemistry by Means of Widely Agreed-Upon Markers (Cytokeratins 5/6 and 7, p63, Thyroid Transcription Factor-1, and Vimentin) on Small Biopsies of Non-small Cell Lung Cancer Effectively Parallels the Corresponding Profiling and Eventual Diagnoses on Surgical Specimens

mTOR Pathway Expression as Potential Predictive Biomarker in Patients with Advanced Neuroendocrine Tumors Treated with Everolimus

Diagnosis of anaplastic lymphoma kinase rearrangement in cytological samples through a fluorescence in situ hybridization–based assay: Cytological smears versus cell blocks

ALK Rearrangement Testing by FISH Analysis in Non–Small-Cell Lung Cancer Patients: Results of the First Italian External Quality Assurance Scheme

Aktive Filter

Suchergebnisse filtern